Clinical Trial Update: A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase III superiority trial comparing vernakalant with amiodarone for recent-onset atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)
• Brinavess (vernakalant hydrochloride)

Snippet

Sponsor: Advanz Pharma | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED